About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The goal of the Shock, Organic Dysfunction and Resuscitation Research Group (SODIR) is comprehensive, innovative research into the areas of shock, acute respiratory failure, acute kidney failure, organic dysfunction, resuscitation and critical patient monitoring. In addition, the research group has a special interest in applying artificial intelligence as an instrument to find innovative solutions for critical patients.
PMID: 35655660 Journal: The Lancet regional health. Europe Year: 2022 Reference: Lancet Reg Health Eur. 2022 May 29;18:100422. doi: 10.1016/j.lanepe.2022.100422. eCollection 2022 Jul. Impact factor: 0 Publication type: Paper in international publication Authors: Boado Varela, Maria Victoria, Suarez-Sipmann, Fernando, Pozo-Laderas, Juan Carlos, Sole-Violan, Jordi, Nieto, Maite, Novo, Mariana Andrea, Barberan, Jose, Amaya Villar, Rosario, Garnacho-Montero, Jose, Garcia-Garmendia, Jose Luis et al. DOI: 10.1016/j.lanepe.2022.100422
PMID: 35603455 Journal: Emerging Microbes & Infections Year: 2022 Reference: Emerg Microbes Infect. 2022 Dec;11(1):1537-1549. doi: 10.1080/22221751.2022.2081615. Impact factor: 7.163 Publication type: Paper in international publication Authors: Garcia-Gasulla, Dario, Menendez, Rosario, Motos, Ana, Penuelas, Oscar, Riera, Jordi, Torres, Antoni, Barbe, Ferran, Gonzalo-Calvo, David de, Ferrer, Ricard, Fernandez-Barat, Laia et al. DOI: 10.1080/22221751.2022.2081615
PMID: 35550352 Journal: Medicina Intensiva Year: 2022 Reference: Med Intensiva (Engl Ed). 2022 Jul;46(7):403-405. doi: 10.1016/j.medine.2022.04.012. Epub 2022 May 9. Impact factor: 2.491 Publication type: Letter or abstract Authors: Pacheco-Reyes, A, Garcia-de-Acilu, M, Roca, O et al. DOI: 10.1016/j.medine.2022.04.012
PMID: 35537897 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2022 Reference: Arch Bronconeumol. 2022 Jun;58(6):523-525. doi: 10.1016/j.arbres.2022.03.002. Epub 2022 Mar 21. Impact factor: 4.872 Publication type: Letter whit IF Authors: Chiscano-Camon, Luis, Ballesteros-Reviriego, Gonzalo, Ruiz-Rodriguez, Alba, Planas-Pascual, Bernat, Perez-Carrasco, Marcos, Gomez-Garrido, Alba, Contreras, Sofia, Spiliopoulou, Stefania, Ferrer, Ricard et al. DOI: 10.1016/j.arbres.2022.03.002
PMID: 33591008 Journal: CRITICAL CARE MEDICINE Year: 2021 Reference: Crit Care Med. 2021 Apr 1;49(4):598-622. doi: 10.1097/CCM.0000000000004895. Impact factor: Publication type: Paper in international publication Authors: Antonelli, Massimo; Bauer, Seth R; Coopersmith, Craig M; De Backer, Daniel; Deutschman, Clifford S; Evans, Laura E; Ferrer, Ricard; Hellman, Judith; Jog, Sameer; Kesecioglu, Jozef et al. DOI: 10.1097/CCM.0000000000004895
PMID: 33231411 Journal: Minerva Anestesiologica Year: 2021 Reference: Minerva Anestesiol. 2021 Jan;87(1):1-3. doi: 10.23736/S0375-9393.20.15195-2. Epub 2020 Nov 24. Impact factor: Publication type: Letter or abstract Authors: Abella, Benjamin S; Ferrer, Ricard; Kucher, Nils; Peluso, Lorenzo; Sunde, Kjetil; Taccone, Fabio S et al. DOI: 10.23736/S0375-9393.20.15195-2
PMID: 33290816 Journal: JOURNAL OF HOSPITAL INFECTION Year: 2021 Reference: J Hosp Infect. 2021 Feb;108:158-167. doi: 10.1016/j.jhin.2020.12.001. Epub 2020 Dec 5. Impact factor: Publication type: Paper in international publication Authors: Bedos, J P; Daikos, G; Dodgson, A R; Ferrer, Ricard; Pan, A; Petrosillo, N; Seifert, H; Vila, J; Wilson, P et al. DOI: 10.1016/j.jhin.2020.12.001
PMID: 33058795 Journal: LANCET INFECTIOUS DISEASES Year: 2021 Reference: Lancet Infect Dis. 2021 Feb;21(2):226-240. doi: 10.1016/S1473-3099(20)30796-9. Epub 2020 Oct 12. Impact factor: Publication type: Paper in international publication Authors: Ariyasu, Mari; Bassetti, Matteo; Doi, Yohei; Echols, Roger; Ferrer, Ricard; Lodise, Thomas P; Matsunaga, Yuko; Naas, Thierry; Nagata, Tsutae D; Niki, Yoshihito et al. DOI: 10.1016/S1473-3099(20)30796-9
PMID: 32416783 Journal: LANCET Year: 2020 Reference: Lancet. 2020 May 16;395(10236):e89. doi: 10.1016/S0140-6736(20)30751-0. Impact factor: 60.392 Publication type: Letter whit IF Authors: Riera, Jordi, Argudo, Eduard, Ruiz-Rodriguez, Juan Carlos, Rodriguez-Lecoq, Rafael, Ferrer, Ricard et al. DOI: 10.1016/S0140-6736(20)30751-0
PMID: 32376091 Journal: Medicina Intensiva Year: 2020 Reference: Med Intensiva. 2020 Aug - Sep;44(6):323-324. doi: 10.1016/j.medin.2020.04.002. Epub 2020 Apr 11. Impact factor: 2.363 Publication type: Editorial in national publication Authors: Ferrer, R et al. DOI: 10.1016/j.medin.2020.04.002
PMID: 31759748 Journal: Medicina Intensiva Year: 2020 Reference: Med Intensiva. 2020 May;44(4):251-254. doi: 10.1016/j.medin.2019.10.001. Epub 2019 Nov 20. Impact factor: 2.363 Publication type: Letter or abstract Authors: Burgueno Laguia, P, Argudo, E, Enriquez Corrales, F, Gonzalez Barrutia, V, Sanchez-Satorra, M, Morales-Codina, M et al. DOI: 10.1016/j.medin.2019.10.001
PMID: 32360034 Journal: Medicina Intensiva Year: 2020 Reference: Med Intensiva. 2020 Aug - Sep;44(6):371-388. doi: 10.1016/j.medin.2020.04.001. Epub 2020 Apr 8. Impact factor: 2.363 Publication type: Paper in national publication Authors: Rubio Sanchiz, Olga, Rodriguez Yago, Miguel Angel, Fraile Gutierrez, Virginia, Fuset Cabanes, M Paz, Zapata Fenor, Lluis, Montesinos de la Pena, Manuel Garcia, Ortega Montes, Ana, Navas Perez, Ana, Arias Verdu, Maria Dolores, Pont Castellana, Teresa et al. DOI: 10.1016/j.medin.2020.04.001
On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.
Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.
Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.
